Charles Zhou

Stock Analyst at UBS

(0)
# 4193
Out of 5,311 analysts
13
Total ratings
50.00%
Success rate
-11.70%
Average return
8 Stocks
Name Action Price Target Current % Upside Ratings Updated
FUTU Futu Hldgs
Maintains: Strong Buy
130 136
76.31 78.22% 3 Mar 17, 2025
ZYME Zymeworks
Reiterates: Buy
16
9.36 70.94% 1 Mar 8, 2023
COGT Cogent Biosciences
Initiates Coverage On: Buy
15
4.13 263.2% 1 Jun 28, 2022
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 May 5, 2022
PMVP PMV Pharma
Initiates Coverage On: Buy
56
0.89 6192.13% 1 Aug 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
0.92 4900% 1 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 3 Aug 25, 2017